Suramin treatment of human glioma xenografts; effects on tumor vasculature and oxygenation status.

作者: H.J.J.A. Bernsen , P.F.J.W. Rijken , J.P.W. Peters , J.H. Bakker , R.H. Boerman

DOI: 10.1023/A:1006363215260

关键词:

摘要: In this study the effect of suramin on tumor growth, vascularity and oxygenation a human glioma xenografted in nude mouse was examined. Vascular parameters status xenografts were determined immunohistochemically frozen sections tumors, using hypoxia marker pimonidazole-hydrochloride to detect hypoxic areas. Tumor vessels these stained by an endothelial cell perfusion visualized administration Hoechst 333342 before harvesting tumors. The vascular quantified with image analysis system. results show that growth reduced considerably after treatment. This suppression accompanied marked changes architecture. Although total area perfused fraction remained unchanged treatment, density increased, indicating more but smaller vessel structures had developed during therapy. These also homogeneously spread over area. Control tumors showed extensive areas while treated mostly disappeared. probably due higher distributed contributing increased tumor. observations suggest therapy can result not only which may have important consequences for sensitivity other therapies such as radiation

参考文章(38)
Yoshihiro Kakeji, Beverly A. Teicher, Preclinical studies of the combination of angiogenic inhibitors with cytotoxic agents Investigational New Drugs. ,vol. 15, pp. 39- 48 ,(1997) , 10.1023/A:1005718628223
H.J.J.A. Bernsen, P.F.J.W. Rijken, H. Peters, H. Bakker, A.J. van der Kogel, The effect of the anti-angiogenic agent TNP-470 on tumor growth and vascularity in low passaged xenografts of human gliomas in nude mice Journal of Neuro-oncology. ,vol. 38, pp. 51- 57 ,(1998) , 10.1023/A:1005957201431
A. Gagliardi, H. Hadd, D. C. Collins, Inhibition of angiogenesis by suramin. Cancer Research. ,vol. 52, pp. 5073- 5075 ,(1992)
Bruno Allolio, Angela Firsching, Patricia Mora, Peter Nickel, Antiproliferative and Angiostatic Activity of Suramin Analogues Cancer Research. ,vol. 55, pp. 4957- 4961 ,(1995)
Rakesh K. Jain, Determinants of Tumor Blood Flow: A Review Cancer Research. ,vol. 48, pp. 2641- 2658 ,(1988)
Damayanthi Devineni, James M. Gallo, Andres Klein-Szanto, Uptake of Temozolomide in a Rat Glioma Model in the Presence and Absence of the Angiogenesis Inhibitor TNP-470 Cancer Research. ,vol. 56, pp. 1983- 1987 ,(1996)
William F. Herblin, Herbert H. Engelhard, Stephen Gately, Janet L. Gross, Kristi Eidsvoog, Mary E. Neville, Shingo Takano, Michael Perricone, Steven Brem, Suramin, an anticancer and angiosuppressive agent, inhibits endothelial cell binding of basic fibroblast growth factor, migration, proliferation, and induction of urokinase-type plasminogen activator. Cancer Research. ,vol. 54, pp. 2654- 2660 ,(1994)
Tumor Angiogenesis: A Quantitative Method for Histologic Grading Journal of the National Cancer Institute. ,vol. 48, pp. 347- 356 ,(1972) , 10.1093/JNCI/48.2.347
Friedrich Kallinowski, Paul Okunieff, Peter Vaupel, Blood Flow, Oxygen and Nutrient Supply, and Metabolic Microenvironment of Human Tumors: A Review Cancer Research. ,vol. 49, pp. 6449- 6465 ,(1989)
K Jin Kim, Bing Li, Jane Winer, Mark Armanini, Nancy Gillett, Heidi S Phillips, Napoleone Ferrara, None, Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo Nature. ,vol. 362, pp. 841- 844 ,(1993) , 10.1038/362841A0